Holtsville, NY, United States of America

Douglas S Werner

This inventor holds 20 USPTO granted patents and 8 published patent applications and 6 EPO patents, primarily in Protein Kinase Inhibitors. Top assignees: Osi Pharmaceuticals, Inc., Blinkbio, Inc.. Active years: 2008-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Douglas S Werner. Retrieved from https://idiyas.com/inventor/douglas-s-werner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 8)

% Patents Active = 70.0

EPO Patents = 6 (Patent Applications = 10)

Average Co-Inventor Count = 6.2

ph-index = 7

Forward Citations = 171(Granted Patents)

Location History:

Northport, NY (US) (2009)
Farmingdale, NY (US) (2010)
Holtsville, NY (US) (2008 - 2014)
Babylon, NY (US) (2014)
West Palm Beach, FL (US) (2018 - 2022)

Company Filing History:

14 out of 118

Osi Pharmaceuticals, Inc.

Years Active: 2008-2022

Loading Chart...

Areas of Expertise:

Silanol Therapeutic Payloads

Silicon Drug Conjugates

Bicyclic Protein Kinase Inhibitors

mTOR Inhibitors

Fused Bicyclic Compounds

Imidazotriazines

2-Aminopyridine Inhibitors

Heterobicyclic Compounds

Tyrosine Kinase Inhibitors

Drug Conjugates

Bicyclic Ring Structures

Protein Kinase Inhibitors

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11497757 - Silanol based therapeutic payloads (2022-11-15),

2. 11291731 - Silicon based drug conjugates and methods of using same (2022-04-05),

3. 10716801 - Silanol based therapeutic payloads (2020-07-21),

4. 10293053 - Silanol based therapeutic payloads (2019-05-21),

5. 10064880 - Silanol based therapeutic payloads (2018-09-04),

6. 9931407 - Silicon based drug conjugates and methods of using same (2018-04-03),

7. 8796455 - Fused bicyclic mTOR inhibitors (2014-08-05),

8. 8735405 - 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors (2014-05-27),

9. 8314111 - Fused bicyclic motor inhibitors (2012-11-20),

10. 8178668 - 2-aminopyridine kinase inhibitors (2012-05-15),

11. 8101613 - 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors (2012-01-24),

12. 7943767 - Fused bicyclic mTOR inhibitors (2011-05-17),

13. 7923555 - Fused bicyclic mTor inhibitors (2011-04-12),

14. 7820662 - 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors (2010-10-26),

15. 7741324 - Imidazotriazines as protein kinase inhibitors (2010-06-22),

Title: The Innovative Journey of Douglas S. Werner

Introduction: Douglas S. Werner, a distinguished inventor hailing from Holtsville, NY, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Douglas S. Werner holds several patents in the areas of telecommunications, antenna design, and electromagnetic systems, showcasing his expertise and creativity in these domains.

Career Highlights: With a career spanning over two decades, Douglas S. Werner has established himself as a leading figure in the world of inventors. His work has not only garnered critical acclaim but has also revolutionized the way we perceive and utilize technology in our daily lives.

Collaborations: Throughout his career, Douglas S. Werner has collaborated with various industry experts, research institutions, and universities to further enhance his inventions and bring them to fruition. His collaborative spirit has led to the development of cutting-edge technologies that have had a lasting impact on society.

Conclusion: In conclusion, Douglas S. Werner's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his position as a trailblazer in the world of inventors. His contributions continue to inspire future generations of innovators to think outside the box and create solutions that shape the world we live in.

Profile summary based on public USPTO records.